|
PNP Therapeutics, Inc.
|
| Link ID |
246224 |
| Title |
PNP Therapeutics, Inc. |
| Url |
http://www.pnptherapeutics.com/ |
| Description |
Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama. |
| Category |
Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer |
| Keywords |
|
| Date |
Jul 19, 2006 |
| Contact Name |
|
| Email |
|
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer |
| 1. |
Allos Therapeutics, Inc.
|
|
|
Develops and commercializes innovative small molecule drugs, initially for improving cancer treatments. Based in Westminster, Colorado. (Nasdaq: ALTH)
|
| 2. |
Australian Cancer Technology Pty Ltd
|
|
|
Company developing three approaches for cures; Chk1 kinase inhibitor, mutated p53 gene and retroviral display vaccines. Includes announcements, media releases, overview of projects incollaboration with UK, a hospital in Sydney, and corporate details at West Perth, Western Australia.
|
| 3. |
Pivotal BioSciences, Inc.
|
|
|
Management and pipeline of cancer therapeutics licensed from the University of Southern California Keck School of Medicine in Los Angeles, California.
|
| 4. |
Cancer Therapeutics, Inc.
|
|
|
Developing tumor-derived activated cell technology for therapy and vaccines. Overview of principles and contacts in Thomasville Georgia, USA.
|
| 5. |
Biomira Inc.
|
|
|
Develops organic chemistry and immunotherapy technology to produce synthetic therapeutic vaccines targeting proliferative tumors. Resources for patients and professionals and investors, with profile of company based in Edmonton, Alberta. (Nasdaq: BIOM)
|
|
|
